IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
